Variant report
Variant | esv3416003 |
---|---|
Chromosome Location | chr6:30060783-30061168 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:30039304..30041261-chr6:30060958..30063803,2 | MCF-7 | breast: | |
2 | chr6:30059663..30061808-chr6:30067229..30070058,2 | K562 | blood: | |
3 | chr6:30027765..30030437-chr6:30060037..30061710,2 | MCF-7 | breast: | |
4 | chr6:30039555..30048654-chr6:30056865..30065735,15 | MCF-7 | breast: | |
5 | chr6:30059482..30063646-chr6:30064744..30071169,8 | MCF-7 | breast: | |
6 | chr6:30041751..30043519-chr6:30060494..30062224,2 | K562 | blood: | |
7 | chr6:30041901..30046365-chr6:30059553..30065121,9 | MCF-7 | breast: | |
8 | chr6:30058600..30061539-chr6:30062741..30064895,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000204618 | chromatin interactions |
ENSG00000204623 | chromatin interactions |
ENSG00000066379 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7753935 | chr6:30060783-30060784 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs532154836 | chr6:30060810-30060811 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs576919180 | chr6:30060870-30060871 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs375315496 | chr6:30060883-30060884 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs368219146 | chr6:30060911-30060912 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs566524000 | chr6:30060942-30060943 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs11967911 | chr6:30060952-30060953 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs9261384 | chr6:30060972-30060973 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs565998933 | chr6:30060984-30060985 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs371517471 | chr6:30060985-30060986 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs9280886 | chr6:30060988-30060989 | Weak transcription Strong transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs28454792 | chr6:30061010-30061011 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs369869617 | chr6:30061028-30061029 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs386698697 | chr6:30061037-30061038 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs17194146 | chr6:30061038-30061039 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs538299692 | chr6:30061048-30061049 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs368834955 | chr6:30061051-30061052 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs17194153 | chr6:30061054-30061055 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs557407130 | chr6:30061057-30061058 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs137957839 | chr6:30061065-30061066 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs17194160 | chr6:30061080-30061081 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9261385 | chr6:30061098-30061099 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs545540119 | chr6:30061109-30061110 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs182401190 | chr6:30061115-30061116 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs374641787 | chr6:30061157-30061158 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs572452476 | chr6:30061166-30061167 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:30058400-30062200 | Strong transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr6:30058600-30061000 | Enhancers | Fetal Intestine Small | intestine |
3 | chr6:30058600-30061400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr6:30060000-30063000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr6:30060000-30063000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr6:30060000-30063000 | Weak transcription | A549 | lung |
7 | chr6:30060000-30064800 | Weak transcription | Gastric | stomach |
8 | chr6:30060200-30061000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr6:30060200-30063000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr6:30060200-30063000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr6:30060200-30063000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr6:30060200-30063000 | Weak transcription | NHEK | skin |
13 | chr6:30060200-30063200 | Weak transcription | HMEC | breast |
14 | chr6:30060200-30065600 | Weak transcription | Spleen | Spleen |
15 | chr6:30060400-30063000 | Weak transcription | Hela-S3 | cervix |
16 | chr6:30060400-30065200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
17 | chr6:30060600-30061000 | Weak transcription | Stomach Mucosa | stomach |
18 | chr6:30061000-30061200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr6:30061000-30062000 | Weak transcription | Fetal Intestine Small | intestine |
20 | chr6:30061000-30062400 | Bivalent Enhancer | HepG2 | liver |
21 | chr6:30061000-30066800 | Enhancers | Stomach Mucosa | stomach |